These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23127512)

  • 21. The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
    Funke M; Zhao Z; Xu Y; Chun J; Tager AM
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):355-64. PubMed ID: 22021336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor.
    Jongsma M; Matas-Rico E; Rzadkowski A; Jalink K; Moolenaar WH
    PLoS One; 2011; 6(12):e29260. PubMed ID: 22195035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
    E S; Lai YJ; Tsukahara R; Chen CS; Fujiwara Y; Yue J; Yu JH; Guo H; Kihara A; Tigyi G; Lin FT
    J Biol Chem; 2009 May; 284(21):14558-71. PubMed ID: 19293149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
    Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
    J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
    Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
    J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
    Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
    PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer.
    Meng Y; Kang S; Fishman DA
    FEBS Lett; 2005 Feb; 579(5):1311-9. PubMed ID: 15710431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
    Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
    Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Li HY; Oh YS; Choi JW; Jung JY; Jun HS
    Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
    Nakanaga K; Hama K; Kano K; Sato T; Yukiura H; Inoue A; Saigusa D; Tokuyama H; Tomioka Y; Nishina H; Kawahara A; Aoki J
    J Biochem; 2014 Apr; 155(4):235-41. PubMed ID: 24451492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
    Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
    J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
    Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
    J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current progress in non-Edg family LPA receptor research.
    Yanagida K; Kurikawa Y; Shimizu T; Ishii S
    Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
    Budd DC; Qian Y
    Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts.
    Maeda-Sano K; Gotoh M; Morohoshi T; Someya T; Murofushi H; Murakami-Murofushi K
    Biochim Biophys Acta; 2014 Sep; 1841(9):1256-63. PubMed ID: 24845645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autotaxin-lysophosphatidic acid-LPA
    Aikawa S; Kano K; Inoue A; Wang J; Saigusa D; Nagamatsu T; Hirota Y; Fujii T; Tsuchiya S; Taketomi Y; Sugimoto Y; Murakami M; Arita M; Kurano M; Ikeda H; Yatomi Y; Chun J; Aoki J
    EMBO J; 2017 Jul; 36(14):2146-2160. PubMed ID: 28588064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.